STRATEGIC FOCUS
Focusing on early stage clinical research companies that are requiring working capital for developmental growth. Bio tech is our primary target.
CKG Management does not sell or trade securities and does not hold any series license issued under the FINRA.
Copyright © 2015 CKG Management - All Rights Reserved.